Bioxcel Therapeutics Inc (BTAI)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BTAI? Forum Prognose

Finanzdaten der Bioxcel Therapeutics Inc-Aktie (BTAI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	54.79% 0.582	0.376	0.341	0.457	0.206
Cost Of Revenue	88.80% 0.08	0.714	0.512	0.026	0.009
Gross Profit	248.52% 0.502	-0.338	-0.171	0.431	0.197
Operating Expenses	26.25% 24.66	19.54	48.13	52.84	51.40
Interest Income/Expense	5.01% 3.607	3.435	3.252	3.259	3.367
Benefits Costs and Expenses	20.95% 27.37	22.63	48.64	52.87	53.00
Costs And Expenses	22.19% 24.75	20.25	48.64	52.87	51.40
Operating Income/Loss	21.57% -24.16	-19.88	-48.30	-52.41	-51.20
Income/Loss From Continuing Operations Before Tax	20.38% -26.79	-22.26	-48.30	-53.52	-52.80
Income/Loss From Continuing Operations After Tax	20.38% -26.79	-22.26	-50.49	-53.52	-52.80
Net Income/Loss	20.38% -26.79	-22.26	-50.49	-53.52	-52.80
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	29,869% 30.87	0.103	29.27	29.19	28.62
Diluted Average Shares	29,869% 30.87	0.103	29.27	29.19	0.0286
Basic Earnings Per Share	16.00% -0.87	-0.75	-1.72	-1.83	-1.84
Diluted Earnings Per Share	16.00% -0.87	-0.75	-1.72	-1.83	-1.84
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

INCY

$70.39

0.93%

SMMT

$18.42

1.07%

MRNA

$38.25

3.55%

UTHR

$367.36

0.83%

BGNE

$194.56

0.15%

BNTX

$108.23

5.96%